Author:
Abbasloo Elham,Dehghan Fatemeh,Khaksari Mohammad,Najafipour Hamid,Vahidi Reza,Dabiri Shahriar,Sepehri Gholamreza,Asadikaram Gholamreza
Abstract
Abstract
Traumatic brain injury (TBI) is a major health concern affecting the general public as well as military personnel. However, there is no FDA-approved therapy for the treatment of TBIs. In this work, we investigated the neurotherapeutic effects of the well-known natural Iranian medicine Satureja Khuzistanica Jamzad (SKJ) essential oil (SKEO) on the outcomes of diffused experimental TBI, with particular attention paid to its anti-inflammatory and anti-apoptotic effects. Male Wistar rats were treated with doses of 50, 100 and 200 (mg/kg, i.p) SKEO after induction of diffused TBIs. The results showed that injecting SKEO (200 mg/kg) 30 minutes after TBI significantly reduced brain oedema and damage to the blood-brain barrier (BBB) and limited the post-TBI increase in intracranial pressure. The veterinary coma scale (VCS) scores significantly improved in the treatment group. Also, inflammatory marker assays showed reduced levels of TNF-α, IL-1β, and IL-6 and increased IL-10 in the treated groups. Moreover, the immunohistochemical results indicated that SKEO not only reduced neuronal death and BBB permeability but also affected astrocytic activation. Overall, our data indicate potential clinical neurological applications for SKEO.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Faul, M., Xu, L., Wald, M., Coronado, V. & Dellinger, A. M. Traumatic brain injury in the United States: national estimates of prevalence and incidence, 2002–2006. InjPrev 16, A268–A268 (2010).
2. Urban, R. J. Hypopituitarism after acute brain injury. Growth Horm IGF Res 16, 25–29 (2006).
3. Chao, P.-K. et al. Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression. J Neuroinflammation 9, 121 (2012).
4. Shlosberg, D., Benifla, M., Kaufer, D. & Friedman, A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6, 393–403 (2010).
5. Lucas, S. M., Rothwell, N. J. & Gibson, R. M. The role of inflammation in CNS injury and disease. Br J Pharmacol 147, S232–S240 (2006).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献